IngredientsBotanical source and common names. Cocoa butter is extracted from cocoa beans, which are the fatty seeds of the cacao tree (Theobroma cacao), a plant native to South and Central America. It is formally known in pharmaceutical and cosmetic science as theobroma oil. Its CAS numbers are 84649-99-0 and 8002-31-1, and its INCI name is Theobroma Cacao Seed Butter.
Etymology. The scientific name Theobroma cacao was given to the species by the Swedish botanist Carl Linnaeus in 1753 when he published it in Species Plantarum. Theobroma means "food of the gods" in Latin, and "cacao" is derived from the Nahuatl (Aztec language) word xocolatl, from xococ (bitter) and atl (water).
Taxonomy and cultivar groups. The cacao tree is a small (6–12 m tall) evergreen in the family Malvaceae. The traditional classification of cacao assumes three major groups with distinct historical, commercial, and morphological features: the Forastero or Amazon group, the ancient cultivar Criollo ("native"), and the Trinitario (from Trinidad) group, presumably derived from crossings between the Forastero and Criollo types. Forastero genotypes are traditionally cultivated in Brazil and West African countries, and represent most of the commercial production of cacao.
Physical characteristics. Cocoa butter, also known as theobroma oil, is a fat that melts over a narrow temperature range of 34°C–36°C and exists in four polymorphic forms, with the stable beta form melting at 34.5°C. Its unique fatty acid composition and distribution on the triglyceride molecule make it brittle below 27°C and able to melt sharply in the mouth. It is also extremely resistant to rancidity. Cocoa butter is one of the most stable fats known; this quality, coupled with natural antioxidants that prevent rancidity, grants it a storage life of two to five years.
Seed composition. Between 20 and 60 beans grow inside a single cacao pod, along with a white pulp; each bean is about 55 percent cocoa butter.
Common preparations and forms. Cocoa butter is commercially available in several forms: raw (unrefined) blocks or chips retaining the characteristic chocolate aroma; refined (deodorized) grades used widely in cosmetics and pharmaceuticals; and food-grade (edible) forms meeting pharmacopeial standards such as the United States Pharmacopeia (USP) and National Formulary (NF). Cocoa butter is notable for its composition of glycerolipids (mainly triglycerides), di- and monoglycerides, free fatty acids, phospholipids, glycolipids, and unsaponifiable matter.
Pre-Columbian Mesoamerica. The cacao tree was first domesticated at least 5,300 years ago by the Mayo-Chinchipe culture in South America before it was introduced in Mesoamerica. Cacao was consumed by pre-Hispanic cultures in spiritual ceremonies, and its beans were a common currency in Mesoamerica. The Maya of Central America believed that the tree was sacred and that chocolate derived from the tree's seeds was the food of the gods, which underlies the origin of the tree's scientific name.
Maya and Aztec preparations. Cultures such as the Maya and Aztec civilizations cultivated cacao for ceremonial drinks, trade, and cultural rituals. For Mesoamerican civilizations, cacao was enjoyed primarily as an unsweetened beverage. The Aztecs used cacao beans as currency and prepared a bitter drink from cacao powder, which they refined with spices. While these societies primarily valued cacao beans for beverages and currency, the fats naturally present in cacao—what we now call cocoa butter—were an essential part of the bean's composition.
Traditional medicinal applications. Cocoa has been used for an array of medicinal purposes. Unfermented cocoa seeds and the seed coat are used to treat a variety of ailments including diabetes, digestive, and chest complaints. Cocoa powder, prepared from fermented cocoa seeds, is used to prevent heart disease. Cocoa butter is taken to lower cholesterol levels, although its efficacy is unclear. It is also used widely in foods and pharmaceutical preparations, as well as being used as a rich moisturizer for the skin.
European introduction and industrial development. In the 16th century, Spanish conquerors brought cocoa to Europe, where it quickly became a popular luxury food. However, it was not until the 19th century that industrial processing of cocoa gained importance with the development of cocoa presses and cocoa butter extraction. The modern separation of cocoa butter from cocoa solids emerged as chocolate manufacturing expanded in the 18th and 19th centuries. Pressing cacao beans allowed producers to create both powdered cocoa and cocoa butter as separate ingredients. Once cocoa butter became more widely available, formulators quickly discovered its value beyond food. Its smooth melting point—close to body temperature—made it ideal for cosmetics and personal care products.
The process of extracting cocoa butter from the beans begins when the pods are harvested and then fermented for five to eight days; this method separates the mature beans from the pulp. The beans are then dried, cleaned, roasted, and cracked to begin separating the shells from the nibs, which consist of both cocoa solids and cocoa butter.
Fermentation appears to be necessary to enhance the cocoa butter content that can be extracted from the nibs. Triglyceride and total and linked fatty acid kinetics of the butter remain statistically stable during fermentation, as does unsaponifiable matter. After fermentation and drying, the nibs are hydraulically pressed or subjected to solvent extraction to yield the fat. The butter may be further refined and deodorized for specific applications.
Cocoa butter's characteristics are determined by its fatty acid composition, including oleic, stearic, palmitic, and linoleic acids, combined with glycerol chains to produce triglycerides (POP, POS, and SOS), which are responsible for its functionality.
The three dominant fatty acids and their approximate proportions are well-documented. The three major fatty acids of cocoa butter include palmitic (26%), stearic (34%), and oleic (34%). Cocoa butter, a fat derived from cocoa plants and found predominantly in dark chocolate, contains an average of 33% monounsaturated oleic acid and 33% stearic acid. Linoleic acid is also present in small quantities. Cocoa butter primarily contains stearic acid, oleic acid, palmitic acid, and linoleic acid.
Triglyceride structure. Cocoa butter typically contains 16–20% triglycerides with palmitic acid at sn-1,3 and oleic acid at the sn-2 position; 35–40% triglyceride containing palmitic acid at sn-1, oleic acid at sn-2, and stearic acid at sn-3; and 25–30% triglyceride with sn-1,3 stearic acid and sn-2 oleic acid. The physical characteristics of cocoa butter result from the arrangement of these fatty acids on the triglyceride. There exists a high degree of symmetrical monounsaturated triglycerides that have the unsaturated fatty acid in the 2-position and saturated fatty acids in the 1- and 3-positions.
Stearic acid — exceptional nature. Unlike other fats, stearic acid content (as a triglyceride) in cocoa butter is 28–45%, an exceptional concentration compared to most vegetable fats where stearic acid is typically less than 5%. Unlike other long-chain saturated fatty acids, stearic acid has no effect on lipoprotein cholesterol concentrations in men or women. This property distinguishes cocoa butter from many other saturated fats of concern in cardiovascular nutrition.
Cocoa butter is rich in unsaponifiables consisting of phytosterols and squalene. Phytosterols exist in free and esterified forms (200–300 mg per 100 g fat) in cocoa beans. The most abundantly found are β-sitosterol and stigmasterol, amounting to 59% and 22% of total phytosterols in cocoa beans, respectively.
Cocoa butter has high oxidative stability due to its chemical composition, specifically its high content of saturated fatty acids and natural antioxidants (tocopherols and tocotrienols). The phytosterols have an antioxidizing, cicatrizing, and soothing action (against burns and chapping). Squalene, which is naturally present in the skin and in sebum, helps regenerate the lipid cement of the stratum corneum.
The alignment of fatty acid molecules within triglycerides is responsible for crystal formation, where long-chain fatty acids increase the melting point and allow different crystalline forms to exist. The fatty acid composition of cocoa butter is so unique that the cocoa fat melts at body temperature. This polymorphic behavior—with six known crystalline forms—is of critical importance in both confectionery science and pharmaceutical formulation.
When applied to skin, cocoa butter functions via two primary physical mechanisms: as an emollient (softening and lubricating the skin surface) and as an occlusive agent (forming a physical barrier that retards transepidermal water loss). Squalene, naturally present in the skin and in sebum, helps regenerate the lipid cement of the stratum corneum. Its fatty acid profile closely mimics natural skin lipids, supporting barrier function through direct integration into the lipid bilayer of the stratum corneum.
Cocoa butter sourced from Theobroma cacao is an emollient and an antioxidant. The tocopherols, polyphenols, and phytosterols present in the unsaponifiable fraction contribute antioxidant protection both in topical applications and, to a lesser extent, when consumed as a food ingredient. Phytosterols have an antioxidizing, cicatrizing, and soothing action (against burns and chapping).
A proposed mechanism of particular nutritional relevance is the metabolic fate of stearic acid. Unlike other long-chain saturated fatty acids such as palmitic or myristic acid, stearic acid (C18:0) is rapidly desaturated in vivo to oleic acid (C18:1), an unsaturated fatty acid. Short-term randomized feeding trials suggest cocoa and chocolate may exert beneficial effects on cardiovascular risk via effects on lowering blood pressure, anti-inflammation, anti-platelet function, higher HDL, and decreased LDL oxidation. Additionally, a large body of trials of stearic acid suggests it is indeed cholesterol-neutral.
Cocoa butter, also known as theobroma oil, melts over a narrow temperature range of 34°C–36°C and exists in four polymorphic forms, with the stable beta form melting at 34.5°C. It is used as a suppository base and must be carefully prepared and stored to maintain its stable crystalline structure. As an edible oil that is solid at room temperature but melts at body temperature, it is considered an ideal base for delivering medicinal ingredients, for example as a suppository.
The use of cocoa butter as a topical emollient is its most established application in both cosmetics and dermatology. Its high fatty acid content provides measurable moisturization of the epidermis, and its occlusive properties reduce transepidermal water loss.
Cocoa butter serves to pacify the skin from windburn or sunburn and serves as a base in the preparation of suppositories and pessaries. Cocoa butter has been proven to provide benefits in moisturizing skin, relieving eczema, as well as protecting against premature aging.
Evidence strength: The moisturizing efficacy of occlusive fatty acids, including those present in cocoa butter, is mechanistically well-supported by dermatological science. However, high-quality randomized controlled trials specifically isolating cocoa butter as the active moisturizing agent—distinct from its vehicle effects—are limited.
Cocoa butter is one of the most widely marketed natural remedies for stretch mark prevention during pregnancy. However, the clinical evidence directly contradicts the popular claim.
A key trial was published in the BJOG (British Journal of Obstetrics and Gynaecology). A double-blind, randomized, placebo-controlled trial published in BJOG followed 175 pregnant women; one group used cocoa butter lotion daily until delivery, the other used a plain placebo. The result was no meaningful difference in stretch mark development between the two groups, even when researchers controlled for how consistently the women applied the product. Specifically: of 210 women enrolled, 175 (83%) completed the study. Ninety-one women received the study lotion and 84 received the placebo. There was no difference in the development of striae gravidarum (45.1% versus 48.8%; P = 0.730) or the severity between cases and controls. The conclusion was unambiguous: topical application of a lotion containing cocoa butter does not appear to reduce the likelihood of developing striae gravidarum.
This finding is corroborated by systematic reviews. No topical agent has been proven to prevent or reduce stretch marks. Randomized controlled trials show that cocoa butter doesn't prevent stretch marks; neither does olive oil. A systematic review evaluating treatments in the management of striae distensae found that two trials investigating cocoa butter for this purpose failed to prove any significant benefits from its use.
The mechanistic reason for failure is anatomical: stretch marks don't happen in the epidermis. They happen in the dermis, and no topical butter or lotion penetrates that deep.
Evidence strength: Strong negative evidence. Multiple RCTs and systematic reviews consistently show no significant benefit over placebo for stretch mark prevention. This area has the highest clinical trial volume of any cocoa butter indication.
Because cocoa butter is a major fat component of chocolate, a considerable body of nutrition research has examined its cardiovascular effects, particularly those attributable to its high stearic acid content.
A systematic review published in PMC covering 136 publications (MEDLINE, 1966–2005) examined the relationship between cocoa, stearic acid, flavonoids, and cardiovascular disease risk. The body of short-term randomized feeding trials suggests cocoa and chocolate may exert beneficial effects on cardiovascular risk via effects on lowering blood pressure, anti-inflammation, anti-platelet function, higher HDL, and decreased LDL oxidation. Additionally, a large body of trials of stearic acid suggests it is indeed cholesterol-neutral. However, epidemiologic studies of serum and dietary stearic acid are inconclusive due to many methodologic limitations.
A controlled dietary study examined the specific cholesterol effects of cocoa butter consumption. One study reported an increase in LDL cholesterol after a beef-fat diet (7.6% of energy as stearic acid), but no change in LDL cholesterol after a cocoa butter diet (13.2% of energy as stearic acid).
A review published in Circulation (American Heart Association journal) reported that in general, plant stearic acid neither lowers high-density lipoprotein (HDL) nor increases LDL or total cholesterol. The same review noted that in hypertensive patients, daily consumption of 100 g of flavonoid-rich chocolate over 2 weeks led to significant reductions in total and LDL cholesterol. However, it is important to note that such effects are attributed primarily to the flavonoid fraction (cocoa polyphenols), not to the cocoa butter fat per se.
Regarding coagulation, though an early study suggested that stearic acid may increase factor VIIc, no effect was observed in two other trials. Moreover, additional trials have refuted the earlier small study and, in fact, shown that stearic acid lowered the levels of factor VIIc coagulation factor compared to palmitic and other saturated fatty acids.
Evidence strength: Moderate. The cholesterol-neutrality of stearic acid in cocoa butter is supported by a substantial body of controlled feeding trials. However, most trials are short-term, and the cardiovascular benefits often reported for chocolate consumption are confounded by the concurrent flavonoid content, which is largely absent from isolated cocoa butter. Long-term endpoint trials are lacking.
Cocoa butter is widely used for eczema-prone skin, primarily for its moisturizing and barrier-enhancing properties. Despite popular use, the clinical trial evidence is sparse.
Many people use cocoa butter to relieve the skin dryness of eczema or psoriasis. Although no clinical trials support its use, anecdotal reports suggest it may help. However, the National Eczema Association does not list it as an ingredient that may help eczema-prone skin.
The theoretical basis for use is reasonable: its molecular structure allows it to create a protective barrier on the skin, locking in moisture and preventing water loss. This is particularly beneficial for eczema-prone skin, which often struggles to retain hydration due to a compromised skin barrier.
Evidence strength: Weak — no controlled clinical trial evidence. While the emollient mechanism is plausible and the ingredient is widely used, no RCT has specifically evaluated cocoa butter for atopic dermatitis or eczema as of available literature. The National Eczema Association has not endorsed it as a recommended ingredient.
Historically, cocoa butter has been applied to minor burns, wounds, and chapped skin. The phytosterols and squalene in the unsaponifiable fraction are proposed to support tissue repair. Phytosterols have an antioxidizing, cicatrizing, and soothing action against burns and chapping. Cocoa butter serves to pacify the skin from windburn or sunburn.
Evidence strength: Preclinical/traditional only. No adequately powered human RCTs have been published specifically evaluating cocoa butter's wound-healing efficacy as a stand-alone intervention. Claims derive from traditional use and the established pharmacological activity of individual constituents such as phytosterols in other contexts.
Cocoa butter has a well-established, long-standing role as a pharmaceutical excipient. Cocoa butter can be used as an excipient, such as lubricants, suppository bases. Its use in this context is not as a therapeutic agent but as an inert delivery vehicle. It must be carefully prepared and stored to maintain its stable crystalline structure — a technical challenge, as cocoa butter can exist in multiple polymorphic forms, and inadvertent warming (e.g., during compounding) can produce lower-melting polymorphs that fail to solidify at room temperature.
It is listed in official pharmacopeias including the USP/NF under the monograph name "Theobroma Oil." Its properties as a suppository base — including melting range, compatibility with medicinal agents, and physical behavior — are defined by pharmacopeial standards.
Evidence strength: Established pharmaceutical practice. This is not a clinical therapeutic claim but a formulation science application with extensive regulatory and compounding history.
Cocoa butter has been evaluated in clinical settings across distinct dosage categories:
No standardized therapeutic dosage has been established for cocoa butter as a dietary supplement or standalone topical therapeutic, because it is not approved by regulatory bodies such as the FDA or EMA as a drug. Published studies do not report a uniform dose of isolated cocoa butter as a supplement.
Cocoa butter is considered safe, so long as you are not allergic to the cocoa plant. It has a long history of safe oral and topical use and is classified as Generally Recognized as Safe (GRAS) by the FDA for food use. Cocoa butter is considered safe for use in cosmetics by organizations like the Environmental Working Group (EWG), but more research on this ingredient is still required.
In one study, cocoa butter had a comedogenic rating of 4 on a scale of 0 to 5, where 0 is non-comedogenic and 5 is highly comedogenic, potentially meaning a higher likelihood of clogging pores. Many ingredients used in cosmetics evoke a comedogenic response. The concept of "acne cosmetica" was developed to link the use of certain ingredients to comedone formation. A published PubMed study evaluated this concern directly: in a study of 6 participants, each received patches on the upper back containing cocoa butter, and reflectance confocal microscopy was used to count the number of microcomedones and follicles induced by cocoa butter. The study confirmed cocoa butter's ability to induce microcomedones.
It must be noted that the Fulton comedogenicity scale, on which cocoa butter receives a rating of 4, is 50 years old and has known methodology flaws, so it should be used as a flag, not a verdict. Nevertheless, the practical guidance from dermatologists is that individuals prone to acne and breakouts may not want to use any products that list cocoa butter as one of the first seven ingredients in a product.
Some people may be allergic to cocoa butter, which can cause skin irritation, itching, redness, and swelling. Individuals with known allergy to the cacao plant should avoid cocoa butter in all forms. Patch testing before widespread topical application is advisable in sensitive individuals.
In pharmaceutical compounding, cocoa butter presents a specific technical safety concern: improper handling can cause it to convert from its stable beta crystalline form to a less stable polymorph with a lower melting point. Suppositories prepared from improperly tempered cocoa butter may melt prematurely at room temperature, compromising drug delivery and product integrity. This is a formulation challenge rather than a patient safety issue.
Cocoa butter will not have any caffeine in it, unlike cocoa powder. This is an important distinction for consumers concerned about stimulant intake; the alkaloids theobromine and caffeine are concentrated in the cocoa solids (non-fat portion), not in the extracted fat.
No well-documented drug–drug interactions have been reported specifically for topically applied cocoa butter in the peer-reviewed clinical literature. As a dietary fat consumed in normal food quantities, cocoa butter does not carry known pharmacokinetic interactions with pharmaceuticals. When used as a suppository base, the physical properties of cocoa butter may theoretically affect the release rate of co-incorporated drugs, but this is a formulation science consideration managed by compounding standards rather than a pharmacological interaction.
Health conditions that Cocoa butter may help support.
Body systems that Cocoa butter may help support.
Go back